Cargando…
170 Combination of a Nasal Antihistamine Olopatadine and A Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients not Currently Controlled on Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist
BACKGROUND: For seasonal Allergic Rhinitis (SAR) patients that remain symptomatic on an intranasal antihistamine, Olopatadine or a leukotriene receptor antagonist Montelukast sodium, the combination of intranasal antihistamine with a leukotriene antagonist Montelukast sodium may provide additional e...
Autor principal: | Nsouli, Safa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512723/ http://dx.doi.org/10.1097/01.WOX.0000411927.81072.07 |
Ejemplares similares
-
195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma
por: Ogawa, Norifumi, et al.
Publicado: (2012) -
Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review
por: Di Lorenzo, Gabriele, et al.
Publicado: (2008) -
Efficacy and anti-inflammatory analysis of glucocorticoid, antihistamine and leukotriene receptor antagonist in the treatment of allergic rhinitis
por: Qiu, Chen, et al.
Publicado: (2023) -
236 H1 Antihistamines Influence on Pro-inflammatory Cytokines Level in Patients With Allergic Rhinitis
por: Bocsan, Ioana Corina, et al.
Publicado: (2012) -
148 Levels of F VCAM and ICAM in Patients With Allergic Rhino-Conjunctivitis and H1 Antihistamines
por: Bujor, Ioana Adriana, et al.
Publicado: (2012)